During the past decade, ETG Warszawa conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ETG Warszawa" #1 sponsor was "Anika Therapeutics, Inc." with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "ACELYRIN Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Verona Pharma plc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ETG Warszawa" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ETG Warszawa" are "Atopic Dermatitis" (2 trials), "Chronic Hand Eczema (CHE)" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Knee Osteoarthritis" (1 trials) and "Osteo Arthritis Knee" (1 trials). Many other conditions were trialed in "ETG Warszawa" in a lesser frequency.

Most popular intervention types in "ETG Warszawa" are "Drug" (6 trials), "Device" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cingal" (2 trials), "Monovisc" (2 trials), "Triamcinolone Hexacetonide" (2 trials) and "ABY-035" (1 trials). Other intervention names were less common.

The vast majority of trials in "ETG Warszawa" are 7 trials for "All" genders.

Currently, there are NaN active trials in "ETG Warszawa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in ETG Warszawa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ETG Warszawa, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".